Clinical Trial

BGT007 Cells for the Treatment of Refractory Digestive System Tumors

Name: BGT007 Cells for the Treatment of Refractory Digestive System Tumors — clinical trial record (NCT06104241)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This is an exploratory clinical study evaluating the safety and initial efficacy of BGT007 injection in the treatment of recurrent/metastatic/refractory digestive system tumors

Trial Details

NCT Number	NCT06104241
Lead Sponsor	The Affiliated Hospital of Xuzhou Medical University Collaborators: Guangzhou Bioresette Biomedical Technology Co., Ltd.
Conditions	Gastrointestinal Cancer
Enrollment	14 participants
Start Date	2023-10-22
Primary Completion	2026-10-20 (estimated)
Study Completion	2027-10-20 (estimated)
Updated on ClinicalTrials.gov	2023-10-27